Wolverine Trading’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.17M | Sell |
43,300
-3,800
| -8% | -$519K | ﹤0.01% | 1230 |
|
|
2025
Q2 | $5.96M | Sell |
47,100
-3,800
| -7% | -$466K | 0.01% | 961 |
|
|
2025
Q1 | $6.63M | Sell |
50,900
-2,800
| -5% | -$380K | 0.01% | 838 |
|
|
2024
Q4 | $7.07M | Buy |
+53,700
| New | +$7.55M | 0.01% | 983 |
|
|
2024
Q3 | – | Sell |
-72,400
| Closed | -$9.94M | – | 5046 |
|
|
2024
Q2 | $9.94M | Buy |
+72,400
| New | +$9.66M | 0.01% | 643 |
|
|
2024
Q1 | – | Sell |
-60,600
| Closed | -$8.23M | – | 4823 |
|
|
2023
Q4 | $8.23M | Buy |
+60,600
| New | +$7.39M | 0.01% | 813 |
|
|
2023
Q3 | – | Sell |
-58,800
| Closed | -$7.41M | – | 4762 |
|
|
2023
Q2 | $7.41M | Sell |
58,800
-14,700
| -20% | -$1.91M | 0.01% | 710 |
|
|
2023
Q1 | $9.35M | Buy |
+73,500
| New | +$9.62M | 0.01% | 566 |
|
|
2022
Q1 | – | Sell |
-142,300
| Closed | -$21.9M | – | 5846 |
|
|
2021
Q4 | $21.9M | Buy |
142,300
+43,000
| +43% | +$6.66M | 0.03% | 440 |
|
|
2021
Q3 | $16M | Sell |
99,300
-36,300
| -27% | -$6.11M | 0.02% | 606 |
|
|
2021
Q2 | $22.2M | Buy |
+135,600
| New | +$20.9M | 0.03% | 380 |
|
|
2021
Q1 | – | Sell |
-183,600
| Closed | -$28M | – | 6095 |
|
|
2020
Q4 | $28M | Sell |
183,600
-21,700
| -11% | -$3.1M | 0.04% | 294 |
|
|
2020
Q3 | $27.6M | Buy |
+205,300
| New | +$27.9M | 0.07% | 211 |
|
|
2020
Q2 | – | Sell |
-174,200
| Closed | -$19M | – | 4851 |
|
|
2020
Q1 | $19M | Buy |
+174,200
| New | +$20.1M | 0.06% | 238 |
|
|
2019
Q4 | – | Sell |
-186,500
| Closed | -$18.5M | – | 4862 |
|
|
2019
Q3 | $18.5M | Sell |
186,500
-93,000
| -33% | -$9.74M | 0.05% | 299 |
|
|
2019
Q2 | $30.5M | Buy |
+279,500
| New | +$29.7M | 0.09% | 179 |
|
|
2019
Q1 | – | Sell |
-209,900
| Closed | -$19.9M | – | 4835 |
|
|
2018
Q4 | $19.9M | Buy |
209,900
+84,800
| +68% | +$9M | 0.06% | 261 |
|
|
2018
Q3 | $15.3M | Buy |
125,100
+49,500
| +65% | +$5.83M | 0.03% | 389 |
|
|
2018
Q2 | $8.07M | Hold |
75,600
| – | – | 0.02% | 607 |
|
|
2018
Q1 | $8.07M | Sell |
75,600
-75,200
| -50% | -$8.34M | 0.02% | 607 |
|
|
2017
Q4 | $16.1M | Buy |
+150,800
| New | +$16.1M | 0.06% | 305 |
|
|
2017
Q3 | – | Sell |
-509,400
| Closed | -$53M | – | 4672 |
|
|
2017
Q2 | $53M | Buy |
+509,400
| New | +$50.2M | 0.24% | 61 |
|
|
2017
Q1 | – | Sell |
-420,600
| Closed | -$37.2M | – | 4595 |
|
|
2016
Q4 | $37.2M | Buy |
420,600
+148,200
| +54% | +$13.5M | 0.18% | 100 |
|
|
2016
Q3 | $26M | Sell |
272,400
-121,200
| -31% | -$11.5M | 0.12% | 164 |
|
|
2016
Q2 | $33.6M | Buy |
+393,600
| New | +$35.3M | 0.19% | 95 |
|
Other funds holding IBB
CB
Wolverine Trading's IBB Position: Q3 2025 in Review
Wolverine Trading reduced its iShares Biotechnology ETF (IBB) stake by 17% in Q3 2025, selling an estimated $348K and leaving 12,539 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2285.
Wolverine Trading first reported a position in IBB in Q2 2016 and has held it in 18 quarters since. The position peaked at $10.4M in Q2 2017. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.
- Wolverine Trading held 12,539 shares of iShares Biotechnology ETF worth $1.79M as of Q3 2025.
- Wolverine Trading sold 2,553 iShares Biotechnology ETF shares in Q3 2025, an estimated $348K.
- iShares Biotechnology ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2285 holding.
- Wolverine Trading first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 18 quarters since.
- Wolverine Trading's iShares Biotechnology ETF position peaked at $10.4M in Q2 2017.
- 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.